Before using Wegovy, tell your healthcare provider if you have any other medical conditions, including if you: have or have had problems with your pancreas or kidneys
Regular check-ins ensure that your progress is tracked, questions are answered, and your treatment plan is adjusted for the best possible results
Wegovy highlights of prescribing information, Novo Nordisk Inc
How Semaglutide Lowers Appetite And Improves Satiety Semaglutide's effectiveness in weight loss comes from its multi-faceted impact on your body's appetite control system
The SELECT trial (NEJM, 2023) demonstrated that semaglutide 2.4mg reduced major adverse cardiovascular events (MACE) by 20% in over 17,000 patients with overweight/obesity and established cardiovascular disease, without diabetes
Official Recommendations from Novo Nordisk Novo Nordisk, Ozempics maker, has specific advice for its use in patients with gallbladder issues or those who had gallbladder surgery